The decision by the NHS to reimburse MED2002 (Futura’s topical treatment for erectile dysfunction) marks an important step towards the launch of the product as a Special (unlicensed medicine) in the UK later this year. The announcement follows the recent news that Futura had out-licensed UK manufacturing and distribution rights to MED2002 as a Special to Quantum Pharma. We are excited about the upcoming launch, as MED2002 can be used to treat the significant proportion (c. 7.5%) of patients with ....
23 Oct 2015
NHS reimbursement agreed for MED2002
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
NHS reimbursement agreed for MED2002
Futura Medical plc (FUM:LON) | 35.7 -0.1 (-0.6%) | Mkt Cap: 107.7m
- Published:
23 Oct 2015 -
Author:
Dr Jens Lindqvist -
Pages:
3
The decision by the NHS to reimburse MED2002 (Futura’s topical treatment for erectile dysfunction) marks an important step towards the launch of the product as a Special (unlicensed medicine) in the UK later this year. The announcement follows the recent news that Futura had out-licensed UK manufacturing and distribution rights to MED2002 as a Special to Quantum Pharma. We are excited about the upcoming launch, as MED2002 can be used to treat the significant proportion (c. 7.5%) of patients with ....